当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析

康缘药业

(600557)

  

流通市值:84.41亿  总市值:84.41亿
流通股本:5.66亿   总股本:5.66亿

康缘药业(600557)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.08亿元,每股收益0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益491278.74万元,未分配利润414805.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产674025.03万元,负债182746.30万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,342,688,380.581,641,577,928.56877,554,089.343,897,668,541.61
营业总成本2,141,450,228.751,488,675,905.49776,267,643.693,601,511,513.81
其他经营收益
营业利润259,963,533.5184,603,338.34104,323,256.95384,517,340.03
利润总额253,141,849.36180,782,407.71103,785,742.54384,763,977.7
净利润207,696,890.52148,708,370.2785,552,385.18380,923,009.12
每股收益
其他综合收益----
综合收益总额207,696,890.52148,708,370.2785,552,385.18380,923,009.12
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,301,633,408.473,449,387,243.713,515,743,605.13,595,905,413.36
非流动资产:
非流动资产合计3,438,616,941.083,383,999,307.843,369,034,487.873,310,856,968.02
资产总计6,740,250,349.556,833,386,551.556,884,778,092.976,906,762,381.38
流动负债:
流动负债合计1,652,177,202.41,790,750,758.951,929,634,774.062,044,480,907.89
非流动负债:
非流动负债合计175,285,765.19188,836,930.89164,500,442.29157,190,982.05
负债合计1,827,462,967.591,979,587,689.842,094,135,216.352,201,671,889.94
所有者权益(或股东权益):
归属于母公司股东权益合计4,714,217,561.424,656,945,168.314,597,988,794.864,514,575,814.65
股东权益合计4,912,787,381.964,853,798,861.714,790,642,876.624,705,090,491.44
负债和股东权益合计6,740,250,349.556,833,386,551.556,884,778,092.976,906,762,381.38
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,862,659,766.361,841,791,492.37996,812,504.484,970,249,944.95
经营活动现金流出小计2,516,534,859.981,697,443,344.52919,876,405.24,267,761,740.64
经营活动产生的现金流量净额346,124,906.38144,348,147.8576,936,099.28702,488,204.31
投资活动产生的现金流量:
投资活动现金流入小计495,891,643.64393,062,810.02228,838,490.052,091,993,122.21
投资活动现金流出小计829,263,338.82620,328,048.27379,391,308.192,106,685,222.49
投资活动产生的现金流量净额-333,371,695.18-227,265,238.25-150,552,818.14-14,692,100.28
筹资活动产生的现金流量:
筹资活动现金流入小计---40,672,313.39
筹资活动现金流出小计23,149,927.5523,172,212.9-542,795,392.37
筹资活动产生的现金流量净额-23,149,927.55-23,172,212.9--502,123,078.98
汇率变动对现金及现金等价物的影响-8,216.49-2,001.517,325.33147,221.47
现金及现金等价物净增加额-10,404,932.84-106,091,304.81-73,609,393.53185,820,246.52
期末现金及现金等价物余额2,157,376,554.52,061,690,182.532,094,172,093.812,167,781,487.34
补充资料:
现金及现金等价物的净增加额--106,091,304.81-185,820,246.52
最新报告期:2025-10-31
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,唐庆雷,张云逸0.710.820.942025-10-31
中信建投袁全,刘若飞,贺菊颖0.610.700.802025-09-05
平安证券叶寅,韩盟盟0.710.800.902025-09-03
华创证券郑辰,高初蕾0.690.800.922025-09-03
华泰证券代雯,唐庆雷,张云逸0.710.820.942025-08-29
TOP↑